share_log

Walgreens Boots Alliance | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Walgreens Boots Alliance Holdings LLC(10.2%),WBA Investments, Inc.(10.2%), etc.

Walgreens Boots Alliance | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Walgreens Boots Alliance Holdings LLC(10.2%),WBA Investments, Inc.(10.2%), etc.

沃爾格林-聯合博姿 | SC 13D/A:超過5%持股股東披露文件(修正)-Walgreens Boots Alliance Holdings LLC(10.2%),WBA Investments, Inc.(10.2%)等
美股SEC公告 ·  08/20 16:09
Moomoo AI 已提取核心訊息
Walgreens Boots Alliance, Inc. (WBA) has filed an amendment with the United States Securities and Exchange Commission (SEC) on August 20, 2024, detailing changes to its ownership and control over Cencora, Inc. The filing, known as Amendment No. 18 to Schedule 13D, indicates that WBA now beneficially owns 19,980,000 shares of Cencora, Inc., representing 10.2% of the company. This ownership stake is based on an adjusted total of 196,007,584 shares of common stock outstanding as of August 5, 2024. The amendment also reports on the Second Amendment to the Amended and Restated Shareholders Agreement between WBA and Cencora, Inc., which was entered into on August 16, 2024. This Second Amendment increases the maximum size of Cencora's board of directors, allowing for additional WBA designees as per the agreement. The filing includes various exhibits related to the transaction, including previous amendments, shareholder agreements, and share repurchase agreements.
Walgreens Boots Alliance, Inc. (WBA) has filed an amendment with the United States Securities and Exchange Commission (SEC) on August 20, 2024, detailing changes to its ownership and control over Cencora, Inc. The filing, known as Amendment No. 18 to Schedule 13D, indicates that WBA now beneficially owns 19,980,000 shares of Cencora, Inc., representing 10.2% of the company. This ownership stake is based on an adjusted total of 196,007,584 shares of common stock outstanding as of August 5, 2024. The amendment also reports on the Second Amendment to the Amended and Restated Shareholders Agreement between WBA and Cencora, Inc., which was entered into on August 16, 2024. This Second Amendment increases the maximum size of Cencora's board of directors, allowing for additional WBA designees as per the agreement. The filing includes various exhibits related to the transaction, including previous amendments, shareholder agreements, and share repurchase agreements.
沃爾格林藥店聯盟(WBA)於2024年8月20日向美國證券交易委員會(SEC)提交了一份修正案,詳細說明其對Cencora公司的所有權和控制發生的變化。該備案文件稱爲第18號修正案13D,表明WBA現在擁有Cencora公司的1998萬股股份,佔該公司的10.2%。該所有權份額基於截至2024年8月5日的普通股已調整總數爲1,960,075,84股。該修正案還報告了WBA與Cencora公司之間修訂和重訂的股東協議的第二修訂案,該修訂案於2024年8月16日簽署。第二修訂案增加了Cencora董事會的最大規模,按照協議允許更多的WBA候選人加入。備案文件包括與交易相關的各種展品,包括以前的修正案、股東協議和股票回購協議。
沃爾格林藥店聯盟(WBA)於2024年8月20日向美國證券交易委員會(SEC)提交了一份修正案,詳細說明其對Cencora公司的所有權和控制發生的變化。該備案文件稱爲第18號修正案13D,表明WBA現在擁有Cencora公司的1998萬股股份,佔該公司的10.2%。該所有權份額基於截至2024年8月5日的普通股已調整總數爲1,960,075,84股。該修正案還報告了WBA與Cencora公司之間修訂和重訂的股東協議的第二修訂案,該修訂案於2024年8月16日簽署。第二修訂案增加了Cencora董事會的最大規模,按照協議允許更多的WBA候選人加入。備案文件包括與交易相關的各種展品,包括以前的修正案、股東協議和股票回購協議。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息